Uncategorized
PanOptica Announces Licensing Agreement with Zhaoke Ophthalmology for PAN-90806 for the Treatment of Neovascular Eye Diseases in China, South Korea, and Southeast Asia
MOUNT ARLINGTON, N.J.--(BUSINESS WIRE)--PanOptica confirms the licensing agreement with Zhaoke Ophthalmology to develop and commercialize PAN-90806 in China, South Korea, and Southeast Asia.